SCHEMBL2817045

SCHEMBL2817045

O=P(OCCc1ccccc1)(OCCc1ccccc1)OCCc1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
TSHR P16473 2/20 0.47
TDP1 Q9NUW8 1/20 0.45
IDO1 P14902 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
CASP1 P29466 1/20 0.42
HSD17B10 Q99714 1/20 0.42
FFAR1 O14842 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11120021 0.92 TSHR (0.55) CA1CA2CA9TSHRTDP1
SCHEMBL3366798 0.91 CA1 (0.46) CA1CA2CA9TSHRTDP1
SCHEMBL28878286 0.90 TSHR (0.48) CA1CA2CA9TSHR
SCHEMBL6828915 0.88 CA2 (0.43) CA1CA2CA9TSHRTDP1
SCHEMBL9555709 0.88 CA1 (0.43) CA1CA2CA9TSHRTDP1
SCHEMBL18787609 0.88 CA2 (0.43) CA1CA2CA9TSHRTDP1
SCHEMBL26981177 0.87 CYP3A4 (0.59)
SCHEMBL26981180 0.87 CYP3A4 (0.59)
SCHEMBL16395023 0.87 L3MBTL1 (0.55) TSHRIDO1L3MBTL1NPC1RAB9A
SCHEMBL6101076 0.86 L3MBTL1 (0.48) CA1CA2CA9TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361353-A1 Curable Photochromic Compositions Including Isocyanate and Imine Functional Components TRANSITIONS OPTICAL LTD (IE) 2025-11-27 US disclosed
US-20240209008-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND TOKYO INSTITUTE OF TECHNOLOGY (JP) 2024-06-27 US disclosed
CN-118159528-A Pyrazole compounds that inhibit Janus kinase and uses thereof 爱瑞制药公司 2024-06-07 CN disclosed
CN-112368284-B Electrochromic compound, electrochromic composition and electrochromic element 株式会社理光 2024-03-08 CN disclosed
EP-3119571-B1 DEACTIVATING COMPOSITION IN THE FORM OF AN INVERT EMULSION CHRYSO (FR) 2024-01-24 EP disclosed
EP-4303222-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND Tokyo Institute of Technology (JP) 2024-01-10 EP disclosed
CN-112368284-A Electrochromic compound, electrochromic composition, and electrochromic element 株式会社理光 2021-02-12 CN disclosed
CN-107109405-A Polynucleotide constructs with Bioreversible and abiotic invertibity group 索尔斯蒂斯生物有限公司 2017-08-29 CN disclosed
US-8604233-B2 Lubricant composition, magnetic recording medium, and novel polyether compound FUJIFILM CORPORATION (JP) 2013-12-10 US disclosed
US-8491811-B2 Lubricant for compression refrigerating machine and refrigerating apparatus using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-07-23 US disclosed
EP-0914963-B1 Thermal transfer image-receiving sheet DAINIPPON PRINTING CO LTD (JP) 2004-08-18 EP disclosed
US-6686073-B2 SUPPORT HAVING LOWER LAYER CONTAINING A NONMAGNETIC POWDER AND A BINDER AND MAGNETIC LAYER CONTAINING A FERROMAGNETIC POWDER AND A BINDER, ELECTROMAGNETIC CHARACTERISTICS AND RUNNING DURABILITY. FUJI PHOTO FILM CO., LTD. (JP) 2004-02-03 US disclosed
US-6677036-B2 FOR HIGH-DENSITY RECORDING HAVING A THIN-LAYER MAGNETIC LAYER FUJI PHOTO FILM CO., LTD. (JP) 2004-01-13 US disclosed
US-20030143323-A1 Method for producing magnetic recording medium and magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-07-31 US disclosed
US-20030138667-A1 Magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-07-24 US disclosed
US-20030118870-A1 Magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-06-26 US disclosed
US-20020090535-A1 Magnetic recording medium FUJIFILM HOLDINGS CORPORATION (JP) 2002-07-11 US disclosed
EP-1207522-A1 Magnetic recording medium FUJI PHOTO FILM CO., LTD. (JP) 2002-05-22 EP disclosed
US-20010053747-A1 THERMAL TRANSFER IMAGE-RECEIVING SHEET DAI NIPPON PRINTING CO., LTD. (JP) 2001-12-20 US disclosed
EP-0914963-A2 Thermal transfer image-receiving sheet DAI NIPPON PRINTING CO., LTD. (JP) 1999-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209008-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND HAO2, PLCB1, PHPT1 CA1 406/4885CA2 152/4885CA9 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.